Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Capital Employed (2016 - 2025)

vTv Therapeutics' Return on Capital Employed history spans 11 years, with the latest figure at 0.56% for Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 6.0% year-over-year to 0.56%; the TTM value through Sep 2025 reached 0.56%, up 6.0%, while the annual FY2024 figure was 1.24%, 97.0% up from the prior year.
  • Return on Capital Employed for Q3 2025 was 0.56% at vTv Therapeutics, up from 1.07% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.41% in Q3 2021 and bottomed at 10.84% in Q4 2023.
  • The 5-year median for Return on Capital Employed is 0.95% (2022), against an average of 1.61%.
  • The largest YoY upside for Return on Capital Employed was 3668bps in 2021 against a maximum downside of -1012bps in 2021.
  • A 5-year view of Return on Capital Employed shows it stood at 1.09% in 2021, then increased by 22bps to 0.85% in 2022, then plummeted by -1183bps to 10.84% in 2023, then skyrocketed by 94bps to 0.68% in 2024, then rose by 17bps to 0.56% in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Return on Capital Employed are 0.56% (Q3 2025), 1.07% (Q2 2025), and 0.81% (Q1 2025).